FDA Inspection 1121058 — North Carolina Center for Reproductive Medicine Inc (NCCRM)
The FDA completed an inspection of North Carolina Center for Reproductive Medicine Inc (NCCRM) on March 16, 2020 in Cary, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 16, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Cary, NC (United States)